Storys zum Thema Medizinische Forschung

ARTTIC Innovation GmbH

canSERV Releases Open Call for Transnational Service Provision

Helmholtz Zentrum München

Interpreting Large-Scale Medical Datasets: ScPoli Enables Multi-Scale Representations of Cells and Samples

The increasing amount of data recorded in medical research can only lead to scientific breakthroughs and essential therapies for patients if interpreted and analyzed correctly. Computer scientists at Helmholtz Munich developed a generative model named scPoli (single-cell population level integration), that performs ...

Helmholtz Zentrum München

A New Ally in Fighting Brain Diseases: Our Very Own Skull

ARTTIC Innovation GmbH

4

PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data Sets

Helmholtz Zentrum München

Life Science Factory to Open a New Location in Munich in 2024

ARTTIC Innovation GmbH

2

CARAMBA: New Hope for Multiple Myeloma Patients

Grünenthal Group

Empowering the Future of Pain Relief Research: Recipients of the 2023 EFIC-Grünenthal Grant Announced

Brussels/Aachen (ots) - - Three promising early-career scientists have been awarded the prestigious EFIC-Grünenthal Grant (E-G-G) 2023. - The E-G-G funds innovative research projects to advance understanding of pain and improve the lives of people suffering from pain. The European Pain Federation EFIC® and the ...

Berlin Cures

Berlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of Innovation and Growth / Phase II study for BC 007 in the indication Long COVID to start in June

Helmholtz Zentrum München

First Integrated Single-Cell Atlas of the Human Lung

Can a human organ be mapped on a single-cell level to learn about the functionality of each individual cell? And can we learn how different these cells are from person to person? Helmholtz Munich researchers and their collaborators have taken up this challenge and developed the Human Lung Cell Atlas using artificial intelligence (AI)-based techniques. This atlas elucidates the diversity of single lung cell types and ...

Medias Klinikum GmbH & Co KG

The Medias Hospital is Raising the Bar for Interventional Oncology as an IASIOS Enrolled Centre

Burghausen/Germany (ots) - The Medias Hospital has officially enrolled in the accreditation program of IASIOS to further ensure highest quality standards in Interventional Oncology as an important aspect of oncological patient care. The Medias Hospital has taken the next step to committing to the highest standards when it comes to interventional oncology (IO) care and ...

eleva GmbH

Björn Cochlovius New CEO of Eleva / Seasoned Molecular Biologist and Entrepreneur Leads German Biotech Company into its Next Development

Freiburg, Germany (ots) - Björn Cochlovius Ph.D. has become the new CEO of Eleva, a Freiburg-based biotech company and the developer of “Bryotechnology”, a unique and pioneering process for the moss-based production of complex therapeutic proteins. The renowned oncologist, immunologist, and molecular biologist ...

Grünenthal Group

Grünenthal and King’s College London collaborate to develop human induced pluripotent stem cell-based microfluidic cultures for pain research

Aachen, Germany and London, England (ots) - - Dr Ramin Raouf from King's College London and Grünenthal strive to develop reliable microfluidic culture models relevant for pain research based on human induced pluripotent stem cell-derived neurons - Grünenthal has expertise in developing human induced pluripotent ...

Debiopharm International SA

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

BOSTON, LAUSANNE & LJUBLJANA, Slovenia (ots) - Debiopharm Innovatoin Fund & Taiwania Capital co-lead financing round for Genialis to propel drug development, diagnostics and treatment planning through AI/ML-enabled platform with a biology-first approach Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, ...

lino Biotech AG

Miltenyi Biotec acquires biosensor company lino Biotech

Zurich (ots) - lino Biotech, a leading biosensor company and the world’s only provider of Focal Molography, announced today it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new biosensors to facilitate quality control in bioprocessing, measuring viral load in cell & gene therapy ...

Helmholtz Zentrum München

Type 1 Diabetes Awareness Campaign - K1DS ARE HEROES - started

Universität Konstanz

Time makes the difference, PI 16/2023

Time makes the difference About 18,000 physicians from Cuba came to Brazil between 2013 and 2018 during the "More Doctors for Brazil" project. The programme aimed at alleviating the public health emergency, however, initially met with surprising resistance, as Konstanz anthropologist Maria Lidola observed in Rio de Janeiro. When countries in the Global ...

Technische Universität München

Nanoswitches for tumor targeting

TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de Video: https://www.youtube.com/watch?v=_xXV0mCke1g NEWS RELEASE Nanoswitches for tumor targeting TUM spin-off Plectonic develops antibody-based immunotherapies Plectonic Biotech, a spin-off of the Technical University of Munich (TUM), has developed a nanoswitch that binds immune cells to tumor cells. The goal is to facilitate the development of ...

Technische Universität München

Tumors: forecasting the risks of brain surgery

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 18198 - email: presse@tum.de - web: www.tum.de This text on the web: http://go.tum.de/619311 Pictures: http://go.tum.de/010709 - http://go.tum.de/959985 - http://go.tum.de/098359 - http://go.tum.de/754050 - http://go.tum.de/109729 Accurately predicting possible post-surgical effects on speech Tumors: forecasting the risks of brain surgery ...

RHEACELL GmbH und Co. KG

Stem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research

Helmholtz Zentrum München

Efficient AI technology for MRI data analysis

Technische Universität München

Viruses help combat antibiotic-resistant bacteria - Cell-free production of bacteriophages

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37533 High resolution images: https://mediatum.ub.tum.de/1678288 NEWS RELEASE Viruses help combat ...

Technische Universität München

New center for digital medicine and health

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37491 Images: https://mediatum.ub.tum.de/1663381 NEWS RELEASE Interdisciplinary research for the digital medicine of the future Federal and state governments approve funding for digital medicine and health center ...

News Direct

ALDERHEY@NYWHERE(TM)

Liverpool, England (ots) - CREATING A HOSPITAL OF THE FUTURE: "A HOSPITAL WITHOUT WALLS" ALDER HEY LAUNCHES GROUND-BREAKING HYBRID DIGITAL HEALTH PLATFORM IN COLLABORATION WITH MICROSOFT AND MINDWAVE "TODAY'S CHILD, TOMORROW'S HEALTHIER ADULT" Alder Hey Children's NHS Foundation Trust, one of the world's leading paediatric healthcare institutions, has today launched a ground-breaking digital platform that is set to revolutionise the way in which patient care is delivered to ...

Technische Universität München

Same symptom – different cause? Algorithms help to distinguish diseases at the molecular level

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37411 High resolution images: https://mediatum.ub.tum.de/1659820 NEWS RELEASE Same symptom – different cause? Algorithms help to distinguish diseases at the ...